Clinical trial

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate…

NCT02855476 · University College, London, Other · Recruiting

Key facts

NCT number NCT02855476
Title HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Official title HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Acronym HDClarity
Lead sponsor University College, London, Other
Collaborators CHDI Foundation, Inc.
Status Recruiting
Study type Observational
Conditions Huntington's Disease
Enrollment 2,500
Start date Jan 1, 2017
Primary completion Apr 30, 2027
First posted Aug 4, 2016
Last update posted Dec 19, 2025
Countries Canada, France, Germany, Italy, New Zealand, Poland, Spain, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies